Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2023-03-15 / Front Cell Infect Microbiol 2023;13:1142172Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-200Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer
/in International Publications, Newcastle Disease Virus, NSCLC /von 2023-02-01 / J Med Virol 2023 Feb;95(2):e28554Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2023-01-31 / Expert Opin Drug Discov 2023 Jan;Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects
/in International Publications, Newcastle Disease Virus /von 2022-11-26 / J Clin Med 2022 Nov;11(23)Immunogenic Cell Death Role in Urothelial Cancer Therapy
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2022-09-18 / Curr Oncol 2022 Sep;29(9):6700-67133-Dimensional coculture of breast cancer cell lines with adipose tissue-Derived stem cells reveals the efficiency of oncolytic Newcastle disease virus infection labeling technology
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2022-09-12 / Front Mol Biosci 2022;9:754100Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2022-09-06 / Molecules 2022 Sep;27(18)Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
/in Brain Tumors in Children, Dendritic Cells, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2022-08-24 / Pharmaceutics 2022 Aug;14(9)IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
- Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
- Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy